Allergy

  • Teva releases late-stage trial results for Qnaze HFA

    JERUSALEM — An investigative treatment for allergies made by Teva Pharmaceutical Industries appears to work, according to results of a late-stage clinical trial released Monday.

     

    Teva said phase-3 data from a study of Qnaze HFA (beclomethasone dipropionate), designed to be inhaled through the nose, was effective in treating patients with seasonal allergic rhinitis, while safety results were similar to those for placebo. Data from the study were presented at the annual meeting of the American College of Allergy, Asthma & Immunology in Phoenix.

  • Hyland’s introduces two homeopathic kids’ remedies for cough-cold/allergy season

    WESTLAKE, Ohio Joining parents this fall in the fight against kids’ cough-cold and allergy symptoms are two new products from homeopathic-medicine provider Hyland’s: Nighttime Cold ’n Cough 4 Kids and Complete Allergy 4 Kids.

    WESTLAKE, Ohio Joining parents this fall in the fight against kids’ cough-cold and allergy symptoms are two new products from homeopathic-medicine provider Hyland’s: Nighttime Cold ’n Cough 4 Kids and Complete Allergy 4 Kids.

  • AAFA releases 'Allergy Capitals' list

    LANDOVER, Md. The Asthma and Allergy Foundation of America on Thursday released its new list of the 100 “Allergy Capitals” (www.AllergyCapitals.com), naming Knoxville, Tenn. as the most challenging place to live with spring allergies this year due to high pollen counts, high use of allergy medications by patients and too few allergists to treat the burgeoning allergy population.

     

  • Target's bull's-eye approach against allergies

    Target started an ad campaign last year called “Ask Us,” and here the retailer is taking a bull's-eye approach against allergies by not only promoting their knowledgeable pharmacists as the friendly neighborhood allergy experts, but also directing consumers as to where they can find the popular decongestant pseudoephedrine.

  • Medco: Just using LABAs to treat asthma puts patients at risk

    FRANKLIN LAKES, N.J. Nearly one-third of patients with asthma are taking their medications in a way that puts them at risk for worsening symptoms and death, according to a new study by pharmacy benefit manager Medco Health Solutions.

  • MinuteClinic begins allergy screenings

    WOONSOCKET, R.I. As trees blossom and shed their pollen, and grasses and weeds germinate in yards, MinuteClinic is reminding allergy sufferers that it can help them take control of their seasonal allergies this spring.

     

X
This ad will auto-close in 10 seconds